Hepatitis B virus surface antigen seroconversion after pegylated interferon-alpha treatment in an HIV-infected individual with chronic hepatitis B

被引:3
|
作者
Rossetti, B. [1 ]
Bianco, C. [1 ]
De Luca, A. [1 ]
机构
[1] Univ Siena, Policlin Le Scotte, Div Infect Dis 2, I-53100 Siena, Italy
关键词
ACTIVE ANTIRETROVIRAL THERAPY; COMBINATION THERAPY; COINFECTION; PATIENT; HBV;
D O I
10.1007/s15010-011-0198-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:347 / 349
页数:3
相关论文
共 50 条
  • [31] Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure
    Wong, Grace Lai-Hung
    Wong, Vincent Wai-Sun
    Yuen, Becky Wing-Yan
    Tse, Yee-Kit
    Yip, Terry Cheuk-Fung
    Luk, Hester Wing-Sum
    Lui, Grace Chung-Yan
    Chan, Henry Lik-Yuen
    JOURNAL OF HEPATOLOGY, 2020, 72 (01) : 57 - 66
  • [32] Efficacy of hepatitis B virus (HBV) vaccination in treating lamivudineresistant HBV reactivation following hepatitis B surface antigen seroconversion
    Gerolami, Rene
    Borentain, Patrick
    Colson, Philippe
    Norguet, Emmanuelle
    Gerolami, Andre
    Tamalet, Catherine
    LIVER INTERNATIONAL, 2007, 27 (10) : 1417 - 1421
  • [33] Advances in treating drug-resistant hepatitis B virus in HIV-infected patients
    Soriano, Vicente
    de Mendoza, Carmen
    Pena, Jose M.
    Barreiro, Pablo
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (02) : 179 - 186
  • [34] Clearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma in a Cohort Chronically Infected with Hepatitis B Virus
    Simonetti, Josephine
    Bulkow, Lisa
    McMahon, Brian J.
    Homan, Chriss
    Snowball, Mary
    Negus, Susan
    Williams, James
    Livingston, Stephen E.
    HEPATOLOGY, 2010, 51 (05) : 1531 - 1537
  • [35] Investigation of Hepatitis B and Hepatitis C Seroprevalence in HIV-infected Patients
    Inci, Ayse
    KLIMIK JOURNAL, 2018, 31 (01) : 34 - 36
  • [36] Interferon-alpha responsible EPN3 regulates hepatitis B virus replication
    Li, Xueqian
    Wang, Zhe
    Zhou, Weiping
    Fu, Xuanhe
    Zhang, Yunpeng
    Sun, Ye
    Yang, Biao
    Bai, Yuxin
    Dai, Chunwei
    Xu, Xiaolun
    Cui, Fan
    Zhao, Ying
    Zhang, Yuping
    Wang, Bengang
    Li, Yingfang
    Muramatsu, Masamichi
    Wakae, Kousho
    Liu, Guangyan
    FRONTIERS IN MEDICINE, 2022, 9
  • [37] Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil
    Mendes-Correa, Maria Cassia
    Pinho, Joao R. R.
    Gomes-Gouvea, Michele S.
    da Silva, Adriana C.
    Guastini, Cristina F.
    Martins, Luiz G.
    Leite, Andrea G.
    Silva, Mariliza H.
    Gianini, Reinaldo J.
    Uip, David E.
    BMC INFECTIOUS DISEASES, 2011, 11
  • [38] Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection
    Chen, Chien-Hung
    Hung, Chao-Hung
    Hu, Tsung-Hui
    Wang, Jing-Houng
    Lu, Sheng-Nan
    Su, Pei-Fang
    Lee, Chuan-Mo
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (11) : 1984 - +
  • [39] Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY)
    Piroth, Lionel
    Sene, Damien
    Pol, Stanislas
    Goderel, Isabelle
    Lacombe, Karine
    Martha, Benoit
    Rey, David
    Loustau-Ratti, Veronique
    Bergmann, Jean-Francois
    Pialoux, Gilles
    Gervais, Anne
    Lascoux-Combe, Caroline
    Carrat, Fabrice
    Cacoub, Patrice
    AIDS, 2007, 21 (10) : 1323 - 1331
  • [40] Prevalence and characteristics of hepatitis B and C virus infections in treatment-na⟨ve HIV-infected patients
    Reuter, Stefan
    Oette, Mark
    Wilhelm, Frank Clemens
    Beggel, Bastian
    Kaiser, Rolf
    Balduin, Melanie
    Schweitzer, Finja
    Verheyen, Jens
    Adams, Ortwin
    Lengauer, Thomas
    Faetkenheuer, Gerd
    Pfister, Herbert
    Haeussinger, Dieter
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2011, 200 (01) : 39 - 49